PPD Development, LP
Clinical trials sponsored by PPD Development, LP, explained in plain language.
A subsidiary of Thermo Fisher Scientific, providing clinical research and drug development services.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New drug trial aims to help patients with severe lung failure
Disease control Recruiting nowThis Phase 2 trial tests a drug called paridiprubart in hospitalized adults with moderate to severe acute respiratory distress syndrome (ARDS), a serious lung condition. About 200 participants will receive either the drug or a placebo as a single IV dose. The main goal is to see …
Phase 2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug trial aims to boost survival in severe lung failure patients
Disease control Recruiting nowThis study tests a medicine called vilobelimab in adults hospitalized with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. About 200 participants will receive either the drug or a placebo to see if it improves survival and is safe…
Phase 2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug trial aims to improve survival in ARDS patients
Disease control Recruiting nowThis study tests a drug called bevacizumab in hospitalized adults with acute respiratory distress syndrome (ARDS), a severe lung condition. About 200 participants will receive either the drug or a placebo to see if it improves survival and oxygen levels. The goal is to find a saf…
Phase 2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New hope for ARDS: major trial tests multiple therapies in hospitalized patients
Disease control Recruiting nowThis study tests several experimental treatments for adults hospitalized with acute respiratory distress syndrome (ARDS), a severe lung condition. About 600 participants will receive either a placebo or an active drug to see if the treatments improve survival and are safe. The go…
Phase 2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC